L-asparaginase-induced hypofibrinogenemia

A case report

O. Balaji, D. Amita, P. Navin

Research output: Contribution to journalArticle

Abstract

Anticancer therapy is always known to cause various side effects. L-asparaginase used in the treatment of adult T-cell lymphoblastic leukemia is a novel class of drug, an enzyme produced from plants as well as microorganisms except human. It is known to cause various adverse reactions including life-threatening neurological complications and thrombotic disorders. Hence, we report a case of hypofibrinogenemia associated with L-asparaginase in a patient treated for T-cell adult lymphoblastic leukemia.

Original languageEnglish
Pages (from-to)11-12
Number of pages2
JournalAsian Journal of Pharmaceutical and Clinical Research
Volume10
Issue number5
DOIs
Publication statusPublished - 01-01-2017
Externally publishedYes

Fingerprint

Asparaginase
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Adult T Cell Leukemia Lymphoma
T-Lymphocytes
Enzymes
Therapeutics
Pharmaceutical Preparations

All Science Journal Classification (ASJC) codes

  • Pharmacology
  • Pharmaceutical Science
  • Pharmacology (medical)

Cite this

Balaji, O. ; Amita, D. ; Navin, P. / L-asparaginase-induced hypofibrinogenemia : A case report. In: Asian Journal of Pharmaceutical and Clinical Research. 2017 ; Vol. 10, No. 5. pp. 11-12.
@article{b3e44c6f54554fa8b066c1e4b59ba9e1,
title = "L-asparaginase-induced hypofibrinogenemia: A case report",
abstract = "Anticancer therapy is always known to cause various side effects. L-asparaginase used in the treatment of adult T-cell lymphoblastic leukemia is a novel class of drug, an enzyme produced from plants as well as microorganisms except human. It is known to cause various adverse reactions including life-threatening neurological complications and thrombotic disorders. Hence, we report a case of hypofibrinogenemia associated with L-asparaginase in a patient treated for T-cell adult lymphoblastic leukemia.",
author = "O. Balaji and D. Amita and P. Navin",
year = "2017",
month = "1",
day = "1",
doi = "10.22159/ajpcr.2017.v10i5.17320",
language = "English",
volume = "10",
pages = "11--12",
journal = "Asian Journal of Pharmaceutical and Clinical Research",
issn = "0974-2441",
publisher = "Innovare Academics Sciences Pvt. Ltd",
number = "5",

}

L-asparaginase-induced hypofibrinogenemia : A case report. / Balaji, O.; Amita, D.; Navin, P.

In: Asian Journal of Pharmaceutical and Clinical Research, Vol. 10, No. 5, 01.01.2017, p. 11-12.

Research output: Contribution to journalArticle

TY - JOUR

T1 - L-asparaginase-induced hypofibrinogenemia

T2 - A case report

AU - Balaji, O.

AU - Amita, D.

AU - Navin, P.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Anticancer therapy is always known to cause various side effects. L-asparaginase used in the treatment of adult T-cell lymphoblastic leukemia is a novel class of drug, an enzyme produced from plants as well as microorganisms except human. It is known to cause various adverse reactions including life-threatening neurological complications and thrombotic disorders. Hence, we report a case of hypofibrinogenemia associated with L-asparaginase in a patient treated for T-cell adult lymphoblastic leukemia.

AB - Anticancer therapy is always known to cause various side effects. L-asparaginase used in the treatment of adult T-cell lymphoblastic leukemia is a novel class of drug, an enzyme produced from plants as well as microorganisms except human. It is known to cause various adverse reactions including life-threatening neurological complications and thrombotic disorders. Hence, we report a case of hypofibrinogenemia associated with L-asparaginase in a patient treated for T-cell adult lymphoblastic leukemia.

UR - http://www.scopus.com/inward/record.url?scp=85018780782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85018780782&partnerID=8YFLogxK

U2 - 10.22159/ajpcr.2017.v10i5.17320

DO - 10.22159/ajpcr.2017.v10i5.17320

M3 - Article

VL - 10

SP - 11

EP - 12

JO - Asian Journal of Pharmaceutical and Clinical Research

JF - Asian Journal of Pharmaceutical and Clinical Research

SN - 0974-2441

IS - 5

ER -